卵巢癌中的VEGF/VEGFR2系统:从功能性到药理学意义
Elisabetta Grillo1, Chiara Romani2, Victoria M Ettorre3
1Department of Molecular and Translational Medicine, University of Brescia, Via Branze 39, 25123 Brescia, Italy.
Biochimica et biophysica acta. Reviews on cancer
|June 14, 2025
概括
血管内皮生长因子受体2 (VEGFR2) 在卵巢癌 (OC) 进展中至关重要. 准这种受体不仅影响血管生长,还影响癌细胞,为OC提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 血管内皮生长因子受体2 (VEGFR2) 是一个关键的氨酸激酶受体,参与胚胎发育,血管生成和癌症.
- VEGFR2信号与卵巢癌 (OC) 的进展有关,这是一个严重的全球健康问题.
- 目前针对VEGF/VEGFR2轴的疗法,最初是作为抗血管生成药物开发的,也影响瘤细胞,免疫细胞和与癌症相关的纤维细胞.
研究的目的:
- 审查VEGF/VEGFR2轴在卵巢癌细胞中的特定作用.
- 从它对癌细胞的作用的角度来讨论向VEGFR2的治疗影响.
- 突出从临床前和临床研究中获得的见解,以改善卵巢癌治疗.
主要方法:
- 对卵巢癌中VEGF/VEGFR2轴的临床前和临床研究的文献综述.
- 对由VEGF/VEGFR2调节的分子景观的分析,在瘤和树皮两部分.
- 对OC中VEGFR2的功能和药理向的当前理解的综合.
主要成果:
- VEGF/VEGFR2轴在卵巢癌的进展中起着复杂的作用,影响多个细胞组件.
- 抗VEGF/VEGFR2药物表现出超越抗血管生成的作用,直接影响卵巢癌细胞.
- 对当前的抗VEGF/VEGFR2疗法的耐药性和次优反应凸显了对途径动态的更深入理解的需要.
结论:
- 向VEGF/VEGFR2轴在卵巢癌中具有显著的治疗潜力,超出其抗血管性作用.
- 了解VEGF/VEGFR2信号对卵巢癌细胞的综合影响对于优化治疗策略至关重要.
- 对VEGFR2抑制的分子机制和临床应用的进一步研究对于提高卵巢癌治疗的疗效和安全性至关重要.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K